Breast Cancer Targeting of a Drug Delivery System through Postsynthetic Modification of Curcumin@N3-bio-MOF-100 via Click Chemistry

被引:57
作者
Alves, Renata C. [5 ]
Schulte, Zachary M. [1 ]
Luiz, Marcela T. [2 ]
da Silva, Patricia Bento [3 ]
Frem, Regina C. G. [4 ]
Rosi, Nathaniel L. [1 ]
Chorilli, Marlus [5 ]
机构
[1] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA
[2] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, BR-14040903 Ribeirao Preto, SP, Brazil
[3] Univ Brasilia UnB, Inst Biol Sci, Dept Genet & Morphol, BR-70910900 Brasilia, DF, Brazil
[4] Sao Paulo State Univ UNESP, Inst Chem, BR-14800970 Araraquara, SP, Brazil
[5] Sao Paulo State Univ UNESP, Dept Drugs & Med, Sch Pharmaceut Sci, BR-14800903 Araraquara, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
METAL-ORGANIC-FRAMEWORK; FOLATE; CURCUMIN; RELEASE; NANOPARTICLES; NANOPLATFORM; CHALLENGES; PLATFORM; DESIGN;
D O I
10.1021/acs.inorgchem.1c00538
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Metal-organic frameworks (MOFs) offer many opportunities for applications across biology and medicine. Their wide range of chemical composition makes toxicologically acceptable formulation possible, and their high level of functionality enables possible applications as delivery systems for therapeutics agents. Surface modifications have been used in drug delivery systems to minimize their interaction with the bulk, improving their specificity as targeted carriers. Herein, we discuss a strategy to achieve a tumor-targeting drug-loaded MOF using "click" chemistry to anchor functional folic acid (FA) molecules on the surface of N-3-bio-MOF-100. Using curcumin (CCM) as an anticancer drug, we observed drug loading encapsulation efficiencies (DLEs) of 24.02 and 25.64% after soaking N-3-bio-MOF-100 in CCM solutions for 1 day and 3 days, respectively. The success of postsynthetic modification of FA was confirmed by H-1 NMR spectroscopy, Fourier transform infrared spectroscopy (FTIR), and liquid chromatography-mass spectrometry (LC-MS). The stimuli-responsive drug release studies demonstrated an increase of CCM released under acidic microenvironments. Moreover, the cell viability assay was performed on the 4T1 (breast cancer) cell line in the presence of CCM@N-3-bio-MOF-100 and CCM@N-3-bio-MOF-100/FA carriers to confirm its biological compatibility. In addition, a cellular uptake study was conducted to evaluate the targeting of tumor cells.
引用
收藏
页码:11739 / 11744
页数:6
相关论文
共 52 条
[1]   A Luminescent Amine-Functionalized Metal-Organic Framework Conjugated with Folic Acid as a Targeted Biocompatible pH-Responsive Nanocarrier for Apoptosis Induction in Breast Cancer Cells [J].
Abazari, Reza ;
Ataei, Farangis ;
Morsali, Ali ;
Slawin, Alexandra M. Z. ;
Carpenter-Warren, Cameron L. .
ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (49) :45442-45454
[2]   Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer [J].
Abazari, Reza ;
Mahjoub, Ali Reza ;
Ataei, Farangis ;
Morsali, Ali ;
Carpenter-Warren, Cameron L. ;
Mehdizadeh, Kayhan ;
Slawin, Alexandra M. Z. .
INORGANIC CHEMISTRY, 2018, 57 (21) :13364-13379
[3]   Metal organic frameworks as a drug delivery system for flurbiprofen [J].
AL Haydar, Muder ;
Abid, Hussein Rasool ;
Sunderland, Bruce ;
Wang, Shaobin .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :2685-2695
[4]   A Critical Review of the Properties and Analytical Methods for the Determination of Curcumin in Biological and Pharmaceutical Matrices [J].
Alves, Renata Carolina ;
Fernandes, Richard Perosa ;
Fonseca-Santos, Bruno ;
Victorelli, Francesca Damiani ;
Chorilli, Marlus .
CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY, 2019, 49 (02) :138-149
[5]   Metal-adeninate vertices for the construction of an exceptionally porous metal-organic framework [J].
An, Jihyun ;
Farha, Omar K. ;
Hupp, Joseph T. ;
Pohl, Ehmke ;
Yeh, Joanne I. ;
Rosi, Nathaniel L. .
NATURE COMMUNICATIONS, 2012, 3
[6]   Cation-Triggered Drug Release from a Porous Zinc-Adeninate Metal-Organic Framework [J].
An, Jihyun ;
Geib, Steven J. ;
Rosi, Nathaniel L. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (24) :8376-+
[7]  
Austin D., 2018, ONCOTARGET, V9
[8]   Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J].
Bianchini, Giampaolo ;
Balko, Justin M. ;
Mayer, Ingrid A. ;
Sanders, Melinda E. ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) :674-690
[9]  
Boughey J. C., 2020, NPJ BREAST CANCER, V6, P1
[10]  
Chalati T, 2011, NANOMEDICINE-UK, V6, P1683, DOI [10.2217/nnm.11.69, 10.2217/NNM.11.69]